The company behind the Covid-19 vaccine being given to people in the UK says it is "highly likely" the vaccine will protect people against the new variant of the virus.
But if necessary, the vaccine could be re-engineered in a matter of weeks, BioNTech's boss said.
UK scientists discovered the variant after analysing a sharp rise in cases in the south-east of England.
Covid jab 'very likely' to protect against new variant https://t.co/jfj5adEerw
— BBCKatharineDaCosta (@KatharineDC) December 22, 2020
They say it could spread up to 70% more quickly than other forms of the virus.
The new variant is thought to be present in many parts of the UK but is particularly concentrated in Kent, Essex and London.
BioNTech, in partnership with drug firm Pfizer, developed the first vaccine against Covid-19 to be approved by an internationally recognised regulatory body - the UK's, in early December.
More than 500,000 people in the UK have now been given their first dose of the vaccine.
The vaccine has also been approved by the US regulator, the FDA, and the European Medicines Agency for use in the EU.
At a news conference in Germany, Ugur Sahin, chief executive of BioNTech, said "scientifically, it is highly likely that [the] immune response by this vaccine also can deal with the new virus variant".
And he added that the company had the technology to refine its vaccine very quickly if it needed to.
"The beauty of the Messenger RNA technology is that we can directly start to engineer a vaccine which completely mimics this new mutation - we could be able to provide a new vaccine technically within six weeks, so that means a vaccine which contains this information," Mr Sahin said.
He confirmed that he didn't know "at the moment" if their vaccine was able to provide protection against this new variant.
Latest Stories
-
FIFA Club World Cup 2025: Sundowns, Esperance join Al Ahly and Wydad as CAF representatives
1 hour -
CAFCL: Al Ahly set up historic final with ES Tunis
2 hours -
We didn’t sneak out 10 BVDs; they were auctioned as obsolete equipment – EC
5 hours -
King Charles to resume public duties after progress in cancer treatment
6 hours -
Arda Guler scores on first start in La Liga as Madrid beat Real Sociedad
6 hours -
Fatawu Issahaku’s Leicester City secures Premier League promotion after Leeds defeat
6 hours -
Anticipation builds as Junior Speller hosts nationwide auditions
7 hours -
Etse Sikanku: The driver’s mate conundrum
7 hours -
IMF Deputy Chief worried large chunk of Eurobonds is used to service debt
8 hours -
Otumfuo Osei Tutu II celebrates 25 years of peaceful rule on golden stool
8 hours -
We have enough funds to pay accruing benefits; we’ve never missed pension payments since 1991 – SSNIT
8 hours -
Let’s embrace shared vision and propel National Banking College – First Deputy Governor
9 hours -
Liverpool agree compensation deal with Feyenoord for Slot
9 hours -
Ejisu by-election: There’s no evidence of NPP engaging in vote-buying – Ahiagbah
9 hours -
Ejisu by-election: Independent ex-NPP MP’s campaign team warns party against dubious tactics
9 hours